PLOS
open access
CC BY 4.0
Does randomization matter in rare disease clinical trials
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ready for the Clinic? A Survey of Open-Source Software for Response-Adaptive Randomization in Clinical Trials#1130781
- Adaptive Sampling of Costly Outcomes in Randomized Clinical Trials#1131229
- Supporting Patient Care With Electronic Resources in the United States#887835
- First Line gastroeSOphageal metastatiC canceR primAry and disTant (if Oligometastatic) lEsions-directed Radiotherapy, a Multicentric, Phase III, Randomized Controlled Trial#879500
- SNooPy: a statistical framework for long-read metagenomic variant calling#253525
Record · ID 637004
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive